What is RDNT's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 5.44B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for RDNT?

P/E (TTM) is n/a and 52-week range is $50.82 to $85.84 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s RDNT figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for RDNT?

The company profile lists revenue (TTM) near $2.27B, net income (TTM) near $-2.11B, EPS (TTM) near $-0.28 when available from the market-data feed. Figures are informational and may lag live markets.

Where is RadNet Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Los Angeles, California, US, 78.6M shares outstanding, ISIN US7504911022 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

RadNet Inc (RDNT) Stock Analysis, Quote & Company Profile

RadNet Inc

$RDNT

Health Care · Health Care Providers & Services

IR Run Scenarios

$69.16

-3.29%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 8,844 full-time employees. The company went IPO on 2001-12-12. The firm has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. The company is also a provider of AI-powered breast health solutions.

Employees

9,060

Website

www.radnet.com/

IPO

2001-12-12

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)